Pharma Journalist -

Seattle Genetics, Inc. and Merck, known as MSD outside the United States and Canada, announced two new strategic oncology collaborations. The companies will globally develop and…
Read More...

Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, and Dynavax Technologies Corporation, a biopharmaceutical company focused on developing…
Read More...

Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs,  announced a vaccine partnership with the UK government for its inactivated…
Read More...

Ansa Biotechnologies announced that it has raised $7.9 million in an oversubscribed Seed round of funding led by Horizons Ventures, with participation from Mubadala Capital, Humboldt…
Read More...

SMi Reports: Renowned industry expert PharMechceutics Ltd to present on the Pre-Filled Syringes and Injectable Drug Devices pre-conference workshop taking place 12th January 2021.…
Read More...

Pfizer Inc. and BioNTech SE announced that they have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment of their Phase 3 pivotal COVID-19…
Read More...

Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company announced a strategic partnership agreement with Hualan Genetic Engineering Co., Ltd (Hualan…
Read More...

Boehringer Ingelheim and Click Therapeutics announced they have entered into a collaboration for the development and commercialization of a prescription-based digital therapeutic. It…
Read More...

Global contract packaging organisation (CPO), Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials. The new…
Read More...

Integral Molecular announces the development of Humanized Chicken Antibody Technology (hCAT) and the incorporation of hCAT into the company's industry-leading MPS antibody discovery…
Read More...